Literature DB >> 18502740

Probing mechanisms of axonopathy. Part I: Protein targets of 1,2-diacetylbenzene, the neurotoxic metabolite of aromatic solvent 1,2-diethylbenzene.

Desire Tshala-Katumbay1, Victor Monterroso, Robert Kayton, Michael Lasarev, Mohammad Sabri, Peter Spencer.   

Abstract

Motor neuron axonopathy in diseases such as amyotrophic lateral sclerosis can be modeled and probed with neurotoxic chemicals that induce similar patterns of pathology, such as axonal spheroids that represent focal accumulation of anterogradely transported neurofilaments (NFs). The aromatic gamma-diketone-like 1,2-diacetylbenzene (1,2-DAB), but not its 1,3-DAB isomer, reacts with epsilon-amino- or sulfyhydryl groups of (neuro)proteins, forms adducts, and causes NFs to accumulate at proximal sites of elongate motor axons. We exploit the protein-reactive properties of neurotoxic 1,2-DAB versus the nonprotein-reactive properties of non-neurotoxic 1,3-DAB to unveil proteomic changes associated with this type of pathology. We used two-dimensional differential in-gel electrophoresis (2D-DIGE), matrix-assisted laser desorption/ionization time-of-flight tandem mass spectrometry to analyze the lumbosacral spinal cord proteome of adult Sprague-Dawley rats treated systemically with 20 mg/kg/day 1,2-DAB, equimolar dose of 1,3-DAB, or equivalent volume of vehicle (saline containing 2% acetone), 5 days a week, for 2 weeks. 1,2-DAB significantly altered the expression of protein disulfide isomerase, an enzyme involved in protein folding, and gelsolin, an actin-capping and -severing protein. Modifications of these two proteins have been incriminated in the pathogenesis of nerve fiber degeneration. Protein-reactive and neurotoxic 1,2-DAB appears to be excellent tool to dissect mechanisms of nerve fiber (axon) degeneration.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18502740      PMCID: PMC2734301          DOI: 10.1093/toxsci/kfn103

Source DB:  PubMed          Journal:  Toxicol Sci        ISSN: 1096-0929            Impact factor:   4.849


  39 in total

1.  Studies on the biochemical basis of distal axonopathies--I. Inhibition of glycolysis by neurotoxic hexacarbon compounds.

Authors:  M I Sabri; C L Moore; P S Spencer
Journal:  J Neurochem       Date:  1979-03       Impact factor: 5.372

2.  Rapid reorganization of the axonal cytoskeleton induced by a gamma diketone.

Authors:  J C Zagoren; M J Politis; P S Spencer
Journal:  Brain Res       Date:  1983-06-27       Impact factor: 3.252

Review 3.  The protein disulphide-isomerase family: unravelling a string of folds.

Authors:  D M Ferrari; H D Söling
Journal:  Biochem J       Date:  1999-04-01       Impact factor: 3.857

4.  General role of GDP dissociation inhibitor 2 in membrane release of Rab proteins: modulations of its functional interactions by in vitro and in vivo structural modifications.

Authors:  A Shisheva; S R Chinni; C DeMarco
Journal:  Biochemistry       Date:  1999-09-07       Impact factor: 3.162

5.  A new murine model of giant proximal axonopathy.

Authors:  D D Tshala-Katumbay; V S Palmer; R J Kayton; M I Sabri; P S Spencer
Journal:  Acta Neuropathol       Date:  2005-03-10       Impact factor: 17.088

6.  In vitro effect of n-hexane and its metabolites on selected enzymes in glycolysis, pentose phosphate pathway and citric acid cycle.

Authors:  M I Sabri
Journal:  Brain Res       Date:  1984-04-09       Impact factor: 3.252

Review 7.  Biliverdin reductase: new features of an old enzyme and its potential therapeutic significance.

Authors:  Urszula M Florczyk; Alicja Jozkowicz; Jozef Dulak
Journal:  Pharmacol Rep       Date:  2008 Jan-Feb       Impact factor: 3.024

8.  Glutathione conjugate formation in the detoxification of ultimate and proximate carcinogens of N-methyl-4-aminoazobenzene.

Authors:  B Coles; B Ketterer; F A Beland; F F Kadlubar
Journal:  Carcinogenesis       Date:  1984-07       Impact factor: 4.944

9.  Detoxification of urotoxic oxazaphosphorines by sulfhydryl compounds.

Authors:  N Brock; J Pohl; J Stekar
Journal:  J Cancer Res Clin Oncol       Date:  1981       Impact factor: 4.553

10.  Glutathione limits Ero1-dependent oxidation in the endoplasmic reticulum.

Authors:  Silvia Nerini Molteni; Anna Fassio; Maria Rosa Ciriolo; Giuseppe Filomeni; Elena Pasqualetto; Claudio Fagioli; Roberto Sitia
Journal:  J Biol Chem       Date:  2004-05-25       Impact factor: 5.157

View more
  11 in total

1.  On the biomarkers and mechanisms of konzo, a distinct upper motor neuron disease associated with food (cassava) cyanogenic exposure.

Authors:  Roman M Kassa; Nyamabo L Kasensa; Victor H Monterroso; Robert J Kayton; John E Klimek; Larry L David; Kalala R Lunganza; Kazadi T Kayembe; Marina Bentivoglio; Sharon L Juliano; Desire D Tshala-Katumbay
Journal:  Food Chem Toxicol       Date:  2010-06-09       Impact factor: 6.023

2.  EepR Mediates Secreted-Protein Production, Desiccation Survival, and Proliferation in a Corneal Infection Model.

Authors:  Kimberly M Brothers; Nicholas A Stella; Eric G Romanowski; Regis P Kowalski; Robert M Q Shanks
Journal:  Infect Immun       Date:  2015-08-31       Impact factor: 3.441

3.  Proximal giant neurofilamentous axonopathy in mice genetically engineered to resist calpain and caspase cleavage of α-II spectrin.

Authors:  R Kassa; V Monterroso; J Wentzell; A L Ramos; E Couchi; M C Lecomte; M Iordanov; D Kretzschmar; G Nicolas; D Tshala-Katumbay
Journal:  J Mol Neurosci       Date:  2012-01-03       Impact factor: 3.444

Review 4.  Neuroprotein Targets of γ-Diketone Metabolites of Aliphatic and Aromatic Solvents That Induce Central-Peripheral Axonopathy.

Authors:  Peter S Spencer
Journal:  Toxicol Pathol       Date:  2020-03-12       Impact factor: 1.902

5.  Integrated hepatic transcriptome and proteome analysis of mice with high-fat diet-induced nonalcoholic fatty liver disease.

Authors:  Irina A Kirpich; Leila N Gobejishvili; Marjorie Bon Homme; Sabine Waigel; Matt Cave; Gavin Arteel; Shirish S Barve; Craig J McClain; Ion V Deaciuc
Journal:  J Nutr Biochem       Date:  2010-03-20       Impact factor: 6.048

6.  Therapeutic effect of the combined use of growth hormone releasing peptide-6 and epidermal growth factor in an axonopathy model.

Authors:  Diana García Del Barco; Héctor Pérez-Saad; Valia Rodríguez; Javier Marín; Viviana Falcón; Jorge Martín; Danay Cibrian; Jorge Berlanga
Journal:  Neurotox Res       Date:  2010-02-19       Impact factor: 3.911

7.  Mutation of crp mediates Serratia marcescens serralysin and global secreted protein production.

Authors:  Robert M Q Shanks; Nicholas A Stella; Kristin E Arena; James E Fender
Journal:  Res Microbiol       Date:  2012-10-13       Impact factor: 3.992

8.  New insights into mechanisms of gamma-diketone-induced axonopathy.

Authors:  Desire Tshala-Katumbay; Paul Desjardins; Mohammad Sabri; Roger Butterworth; Peter Spencer
Journal:  Neurochem Res       Date:  2009-04-29       Impact factor: 3.996

9.  HMG-CoA synthase isoenzymes 1 and 2 localize to satellite glial cells in dorsal root ganglia and are differentially regulated by peripheral nerve injury.

Authors:  Fei Wang; Hongfei Xiang; Gregory Fischer; Zhen Liu; Matthew J Dupont; Quinn H Hogan; Hongwei Yu
Journal:  Brain Res       Date:  2016-09-23       Impact factor: 3.252

10.  Probing mechanisms of axonopathy. Part II: Protein targets of 2,5-hexanedione, the neurotoxic metabolite of the aliphatic solvent n-hexane.

Authors:  Desire Tshala-Katumbay; Victor Monterroso; Robert Kayton; Michael Lasarev; Mohammad Sabri; Peter Spencer
Journal:  Toxicol Sci       Date:  2008-11-25       Impact factor: 4.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.